We thus plan to implement a systematic and exhaustive study as well as an experimental validation of the underlying mechanisms with respect to prognostic IGF2BP1 in breast cancer, with particular emphasis on hub genes in IGF2BP1 regulatory networks. The gene discussed is IGF2BP1; the disease is breast cancer.